Heterocyclic benzazole derivatives with antimycobacterial in vitro activity

Bioorg Med Chem Lett. 2002 Nov 18;12(22):3275-8. doi: 10.1016/s0960-894x(02)00697-2.

Abstract

The series of 2-benzylsulfanyl derivatives of benzoxazole and benzothiazole were synthesized, evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis and non-tuberculous mycobacteria, and the activity expressed as the minimum inhibitory concentration (MIC) in micromol/L. The substances bearing two nitro groups (4e, 4f, 5e, 5f) or a thioamide group (4i, 4j, 5i, 5j) exhibited appreciable activity particularly against non-tuberculous strains. The most active compounds were subjected to the toxicity assay and were evaluated as moderately cytotoxic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / toxicity
  • Benzoxazoles / chemical synthesis*
  • Benzoxazoles / pharmacology*
  • Benzoxazoles / toxicity
  • HeLa Cells
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium avium / drug effects
  • Mycobacterium kansasii / drug effects
  • Mycobacterium tuberculosis / drug effects
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Benzoxazoles